Novo Nordisk Calls for FDA to Prohibit Compounding Pharmacies from Providing Semaglutide
Pharmacy Times
OCTOBER 25, 2024
The call follows the FDA’s sudden removal of tirzepatide from the drug shortage list, preventing compounding pharmacies from providing the drug.
Let's personalize your content